CTRI/2019/11/022007已完成未知
Sero-prevalence of anti-hepatitis A antibodies in four cities from different parts of India - HAV ISS
Bharati Vidyapeeth Deemed to be University Medical College Hospital0 个研究点目标入组 2,230 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 2,230
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1)Age 1-40 years at the time of enrolment.
- •2)Informed consent form signed by either of the parents in case of children or by the participant in case of adults. Assent given by the subject aged between 07-17 years.
排除标准
- •1)Known or suspected congenital or acquired immunodeficiency.
- •2)Documented acute Hepatitis A infection (IgM anti- HAV positive with or without raised LFT parameters).
- •3)Person with serious illness at the time of enrolment or on any critical treatment like chemotherapy, immuno-modulating agents or blood transfusion program etc.
- •4)H/o hepatitis A vaccination.
- •5)Children in care – institutions or orphanages
研究者
相似试验
尚未招募
不适用
To find out prior infection of Hepatitis A in non vaccinated adolescents aged 9-12 yearsCTRI/2022/10/046790Department of Pediatrics
招募中
不适用
To evaluate prevalence of Hepatitis A virus in Indian childreCTRI/2011/09/002005Wockhardt Limited1,068
招募中
4 期
Immune response to hepatitis A vaccine in liver transplanted childreTCTR20220110001/A60
撤回
不适用
Seroprevalence Study of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV) in Patients with Plakophilin 2 (PKP2)-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)ARVCheart disease10028593NL-OMON56804Tenaya Therapeutics Inc.30
招募中
4 期
Immunogenicity of live attenuated hepatitis A vaccine in overweight and obese children/adolescent/young adultOverweight or obesityHepatitis A vaccine,immunogenicity,overweight,obesityTCTR20191230001BIOGENETECH CO., LTD.200